Intellectual Property India Publishes Patent Application for 'Genetically Engineered Cells Having Anti-Nectin4 Chimeric Antigen Receptors, And Uses Thereof' Filed by Century Therapeutics, Inc.

MUMBAI, India, June 27 -- Intellectual Property India has published a patent application (202517053526 A) filed by Century Therapeutics, Inc., Philadelphia, on June 2, for 'genetically engineered cells having anti-nectin4 chimeric antigen receptors, and uses thereof.'

Inventor(s) include Borges, Luis; Carton, Jill, Marinari; Naso, Michael, Francis; Wallet, Mark; Wheeler, John; and Hall, Matthew, S.

The application for the patent was published on June 27, under issue no. 26/2025.

According to the abstract released by the Intellectual Property India: "Provided are genetically engineered induced pluripotent stem cells (iPSCs) and derivative cells thereof expressing an anti-Nectin4 chimeric antigen receptor (CAR) and, optionally, an inhibitory CAR, and methods of using the same. Also provided are compositions, polypeptides, vectors, and methods of manufacturing."

The patent application was internationally filed on Nov. 10, 2023, under International application No.PCT/US2023/079401.

Disclaimer: Curated by HT Syndication.